deuterated phenanthrene

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2007 (NCT01092650)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • deuterated phenanthrene
  • deuterated phenanthrene tetraol
  • phenanthrene-d10

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02999399N/ADec 1, 2016University of Minnesota
NCT01673711N/AJul 1, 2012National Cancer Institute (NCI), University of Minnesota
NCT01092650Phase 1Sep 1, 2007University of Minnesota
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of MinnesotaAcademic/Hospital3322007
National Cancer Institute (NCI)Government1012012
2 organizations
Page 1 / 1